Dana-Farber
Dana-Farber Cancer Institute Receives $50M Gift to Advance Pancreatic Cancer Research
The Hale family's donation will go toward efforts underway at the Hale Family Center for Pancreatic Cancer Research, including precision oncology initiatives.
With a new $16 million NCI grant, Count Me In is working with the Broad and Dana-Farber to engage osteosarcoma and leiomyosarcoma patients in their own care and in research.
In Brief This Week: AstraZeneca, Merck, Amgen, Kintara Therapeutics, Dana Farber Cancer Institute
News items for the week of Feb. 15, 2021.Â
The research may inform the use of a liquid biopsy assay for tracking SMM progression that improves on bone marrow aspirate analysis and is easier for patients to access.
MMRF, Dana Farber Partner on Search for Biomarkers Linked to Smoldering Multiple Myeloma Progression
By identifying these biomarkers, the partners hope to better predict which SMM patients will progress to multiple myeloma and ultimately develop new treatments.
Jul 24, 2020
Jun 25, 2019